Psoriasis Clinical Trials

Showing 761-780 of 1,026 trials

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

NCT00358384

This study is an exploratory study to evaluate the effectiveness, safety and tolerability of three concentrations of GW786034 ointment following treatment to small areas of stable psoriatic plaques. Dosing will proceed using a microplaque approach, where small volumes of ointment will be applied under full occlusion to representative psoriatic plaques. The effectiveness of topical GW786034 treatments and controls will be explored using visual intensity assessments in addition to dermal imaging and histological surrogates of disease activity.

Psoriasis

GlaxoSmithKline10 participantsStarted Sep 2005

Paris, France

TERMINATEDPhase 1

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

NCT02936492

Systemic safety following single and multiple dermal administration of BAY1003803

Psoriasis

Bayer32 participantsStarted Oct 2016

Hamburg, Germany

TERMINATEDPhase 1

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

NCT03145948

This is a study to assess the pharmacokinetics, safety and tolerability of multiple ascending oral doses of ABBV-553 in healthy volunteers and the pharmacokinetics, safety, tolerability and efficacy of multiple ascending oral doses of ABBV-553 in participants with psoriasis under non-fasting conditions.

Psoriasis

AbbVie12 participantsStarted May 2017

Anaheim, California, United States • Toluca, California, United States • Port Orange, Florida, United States +1 more locations

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

Related Searches

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

Mechanism of Action Study for Psoriasis

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque Psoriasis

Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects

Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis

A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects